Modeling the relative influence of socio-demographic variables on post-acute COVID-19 quality of life

Post-acute sequelae of SARS-CoV-2, referred to as "long COVID", are a globally pervasive threat. While their many clinical determinants are commonly considered, their plausible social correlates are often overlooked. To compare social and clinical predictors of differences in quality of li...

Full description

Saved in:
Bibliographic Details
Published inmedRxiv : the preprint server for health sciences
Main Authors Menkir, Tigist F, Citarella, Barbara Wanjiru, Sigfrid, Louise, Doshi, Yash, Reyes, Luis Felipe, Calvache, Jose A, Kildal, Anders Benjamin, Nygaard, Anders B, Holter, Jan Cato, Panda, Prasan Kumar, Jassat, Waasila, Merson, Laura, Donnelly, Christl A, Santillana, Mauricio, Buckee, Caroline, Verguet, Stéphane, Hejazi, Nima S
Format Journal Article
LanguageEnglish
Published United States 09.09.2024
Online AccessGet more information

Cover

Loading…
More Information
Summary:Post-acute sequelae of SARS-CoV-2, referred to as "long COVID", are a globally pervasive threat. While their many clinical determinants are commonly considered, their plausible social correlates are often overlooked. To compare social and clinical predictors of differences in quality of life (QoL) with long COVID. Additionally, to measure how much adjusted associations between social factors and long COVID-associated quality of life are unexplained by important clinical intermediates. Data from the ISARIC long COVID multi-country prospective cohort study. Subjects from Norway, the United Kingdom (UK), and Russia, aged 16 and above, with confirmed acute SARS-CoV-2 infection reporting >= 1 long COVID-associated symptoms 1+ month following infection. The social exposures considered were educational attainment (Norway), employment status (UK and Russia), and female vs male sex (all countries). Quality of life-adjusted days, or QALDs, with long COVID. This cohort study included a total of 3891 participants. In all three countries, educational attainment, employment status, and female sex were important predictors of long COVID QALDs. Furthermore, a majority of the estimated relationships between each of these social correlates and long COVID QALDs could not be attributed to key long COVID-predicting comorbidities. In Norway, 90% (95% CI: 77%, 100%) of the adjusted association between the top two quintiles of educational attainment and long COVID QALDs was not explained by clinical intermediates. The same was true for 86% (73%, 100%) and 93% (80%,100%) of the adjusted associations between full-time employment and long COVID QALDs in the United Kingdom (UK) and Russia. Additionally, 77% (46%,100%) and 73% (52%, 94%) of the adjusted associations between female sex and long COVID QALDs in Norway and the UK were unexplained by the clinical mediators. This study highlights the role of socio-economic status indicators and female sex, in line with or beyond commonly cited clinical conditions, as predictors of long COVID-associated QoL, and further reveal that other (non-clinical) mechanisms likely drive their observed relationships. Our findings point to the importance of COVID interventions which go further than an exclusive focus on comorbidity management in order to help redress inequalities in experiences with this chronic disease. How do social and medical factors compare in predicting differences in quality of life (QoL) with long COVID and to what extent do clinical mediators explain social variables' relationships with long COVID QoL? Socio-economic proxies employment status and educational attainment and female sex ranked on par with or above age and neuropsychological and rheumatological comorbidities as predictors of variation in long COVID QoL across participants. Additionally, estimated adjusted associations between each of these social factors and long COVID QoL were largely unexplained by a set of key comorbidities. Long COVID-based interventions may be more broadly beneficial if they account for social disparities as important risk factors for differential long COVID burden and, in addition to clinical targets, address broader structural determinants of health.
DOI:10.1101/2024.02.21.24303099